Benchmarking Large Language Models for Assay-Aware Drug-Target Binding Affinity Prediction
Machine learning models for molecular discovery often train on bioactivity data from heterogeneous assays, yet assay context is rarely explicitly represented. We investigate whether natural-language assay descriptions provide predictive information beyond molecular and protein representations. We develop ACL-DTI (Assay-aware Contrastive Learning-based Drug Target Interaction) and MAMMAL-AsAP, an…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
